Literature DB >> 2568900

Regional differences in concentrations of regulatory peptides in human colon mucosal biopsy.

J Calam1, M A Ghatei, J Domin, T E Adrian, M Myszor, S Gupta, C Tait, S R Bloom.   

Abstract

The study was undertaken to examine regional differences in the concentrations of five regulatory peptides in the human colonic mucosa. Biopsies were obtained during routine colonoscopy from 33 patients whose colonic mucosa was macroscopically and histologically normal. Regulatory peptides were extracted, and measured by specific radioimmunoassays. Concentrations of three peptides that are present predominantly in endocrine cells within colonic mucosa increased significantly towards the rectum: Mean concentrations of peptide YY, enteroglucagon, and somatostatin were about three times greater in the rectum than in the cecum. However, concentrations of two peptides that are present in mucosal nerve fibers diminished significantly towards the rectum: Mean rectal concentrations of vasoactive intestinal peptide and peptide histidine methionine were both about 0.6 of mean cecal concentrations. Concentrations of all five peptides were lower in biopsies taken from colonic polyps than in normal colonic mucosa. Regional differences in colonic mucosal concentrations of regulatory peptides probably reflect differences in the physiological functions of different parts of the colon.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568900     DOI: 10.1007/BF01537267

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Abnormalities of fasting serum concentrations of peptide YY in the idiopathic inflammatory bowel diseases.

Authors:  T R Koch; D R Roddy; V L Go
Journal:  Am J Gastroenterol       Date:  1987-04       Impact factor: 10.864

2.  Peptide-containing nerve fibres in the gut wall in Crohn's disease.

Authors:  K Sjölund; O B Schaffalitzky; D E Muckadell; J Fahrenkrug; R Håkanson; B G Peterson; F Sundler
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

3.  Measurement of fasting and postprandial plasma VIP in man.

Authors:  S J Mitchell; S R Bloom
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

4.  Correlative immunocytochemical and electron microscopic studies: identification of (entero)glucagon- somatostatin- and pancreatic polypeptide-like-containing cells in the human colon.

Authors:  T Lehy; G Peranzi; M L Cristina
Journal:  Histochemistry       Date:  1981

5.  Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract.

Authors:  M A Ghatei; L O Uttenthal; N D Christofides; M G Bryant; S R Bloom
Journal:  J Clin Endocrinol Metab       Date:  1983-09       Impact factor: 5.958

6.  Isolation and primary structure of human PHI (peptide HI).

Authors:  K Tatemoto; H Jörnvall; T J McDonald; M Carlquist; V L Go; C Johansson; V Mutt
Journal:  FEBS Lett       Date:  1984-09-03       Impact factor: 4.124

7.  Co-existence of glicentin and peptide YY in colorectal L-cells in cat and man. An electron microscopic study.

Authors:  G Böttcher; J Alumets; R Håkanson; F Sundler
Journal:  Regul Pept       Date:  1986-02

8.  Peptide YY abnormalities in gastrointestinal diseases.

Authors:  T E Adrian; A P Savage; A J Bacarese-Hamilton; K Wolfe; H S Besterman; S R Bloom
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

9.  Neuroendocrine cells in colorectal adenomas.

Authors:  H F Van den Ingh; L J Van den Broek; A A Verhofstad; F T Bosman
Journal:  J Pathol       Date:  1986-03       Impact factor: 7.996

10.  Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases.

Authors:  T R Koch; J A Carney; V L Go
Journal:  Dig Dis Sci       Date:  1987-04       Impact factor: 3.199

View more
  5 in total

1.  Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease.

Authors:  H Yamamoto; K Morise; K Kusugami; A Furusawa; T Konagaya; Y Nishio; H Kaneko; K Uchida; H Nagai; T Mitsuma; H Nagura
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

2.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

3.  Slow transit chronic constipation (Arbuthnot Lane's disease). An immunohistochemical study of neuropeptide-containing nerves in resected specimens from the large bowel.

Authors:  A Dolk; G Brodén; B Holmström; C Johansson; M Schultzberg
Journal:  Int J Colorectal Dis       Date:  1990-12       Impact factor: 2.571

4.  Somatostatin in inflammatory bowel disease.

Authors:  J D van Bergeijk; J H Wilson
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

5.  Effect of genetic SSTR4 ablation on inflammatory peptide and receptor expression in the non-inflamed and inflamed murine intestine.

Authors:  Joeri Van Op den Bosch; Pascal Torfs; Benedicte Y De Winter; Joris G De Man; Paul A Pelckmans; Eric Van Marck; David Grundy; Luc Van Nassauw; Jean-Pierre Timmermans
Journal:  J Cell Mol Med       Date:  2009-05-01       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.